Are you a journalist? Please sign up here for our press releases
Subscribe to our monthly newsletter:
Ruth Arnon
10.10.2010
from the institute to Teva Pharmaceuticals Ltd.
01.05.2009
From student to Institute Vice President
10.10.2007
Israeli scientists identify: Genes that Affect Responses of Multiple Sclerosis Patients to Copaxone®
...
01.10.2004
The uncannily devious flu virus, it turns out, has an Achilles’ heel
01.09.2004
Fewer than 10 percent of cancer deaths are caused by tumors growing at their original site; in the majority of cases the...
01.05.1997
Nearly three decades after a surprising discovery, Copaxone® gets FDA approval for the treatment of MS
28.01.1997
REHOVOT, Israel -- January 28, 1997 -- This week, two scientists from Israel's Weizmann Institute were honored for an...
23.12.1996
REHOVOT, Israel -- December 23, 1996 -- The U.S. Food and Drug Administration today announced the approval of the Israeli...
19.09.1996
REHOVOT, Israel -- September 19, 1996 -- An advisory committee convened by the U.S. Food and Drug Administration...
01.10.1995
Dr. Klara Vinokur recently recieved the 1995 Excellence Award for her project undertaken with help from the Kiryat Weizmann...
